References
- SakaiASakataTIkedaSIntermittent administration of human parathyroid Hormone(1–34) prevents immobilization-related bone loss by regulating bone marrow capacity for bone cells in ddY miceJ Bone Miner Res199914101691169910491216
- BellidoTAliAAPlotkinLIProteasomal degradation of Runx2 shortens parathyroid hormone-induced anti-apoptotic signaling in osteoblasts. A putative explanation for why intermittent administration is needed for bone anabolismJ Biol Chem200327850502595027214523023
- MiyauchiAMatsumotoTSugimotoTTsujimotoMWarnerMRNakamuraTEffects of teriparatide on bone mineral density and bone turnover markers in Japanese subjects with osteoporosis at high risk of fracture in a 24-month clinical study: 12-month, randomized, placebo-controlled, double-blind and 12-month open-label phasesBone201047349350220580870
- TsujimotoMChenPMiyauchiASowaHKregeJHPINP as an aid for monitoring patients treated with teriparatideBone201148479880321168536
- EastellRKregeJHChenPGlassEVReginsterJYDevelopment of an algorithm for using PINP to monitor treatment of patients with teriparatideCurr Med Res Opin2006221616616393431
- YamamotoTTaketsunaMGuoXSatoMSowaHThe safety and effectiveness profile of daily teriparatide in a prospective observational study in Japanese patients with osteoporosis at high risk for fracture: interim reportJ Bone Miner Metab201432669970824368586
- FavusMJBushinskyDALemannJJrRegulation of calcium, magnesium, and phosphate metabolismFavusMJPrimer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism6th EdWashington DCAmerican Society for Bone and Mineral Research20067683
- HeaneyRPVitamin D and calcium interactions: functional outcomesAm J Clin Nutr2008882541S544S18689398
- WolfRLCauleyJABakerCEFactors associated with calcium absorption efficiency in pre- and perimenopausal womenAm J Clin Nutr200072246647110919942
- NishizawaYOhtaHMiuraMGuidelines for the use of bone metabolic markers in the diagnosis and treatment of osteoporosis (2012 edition)J Bone Miner Metab201331111523143508
- OrimoHSugiokaYFukunagaMDiagnostic criteria of primary osteoporosisJ Bone Miner Metab199816139150
- SchaferALPalermoLBauerDCBilezikianJPSellmeyerDeBlackDMConsistency of bone turnover marker and calcium responses to parathyroid hormone (1–84) therapy in postmenopausal osteoporosisJ Clin Densitom2011141687321095149
- MillerPDSchwartzENChenPMisurskiDAKregeJHTeriparatide in postmenopausal women with osteoporosis and mild or moderate renal impairmentOsteoporos Int2007181596817013567
- NiimiRKonoTNishiharaAAn algorithm using the early changes in PINP to predict the future BMD response for patients treated with daily teriparatideOsteoporos Int201425137738423812597
- MiyauchiAMatsumotoTShigetaHTsujimotoMThiebaudDNakamuraTEffect of teriparatide on bone mineral density and biochemical markers in Japanese women with postmenopausal osteoporosis: a 6-month dose-response studyJ Bone Miner Metab200826662463418979163
- LopezBGonzalexADiezJCirculating biomarkers of collagen metabolism in cardiac diseasesCirculation2010121141645165420385961
- HannonRBlumsohnANaylorAEastellRResponese of biochemical markers of bone turnover to hormone replacement therapy: impact of biological variabilityJ Bone Min Res199813711241133